Evidence map›Paper›PMID 19914193›Full record

ArticleVaccine2010

Comparison of the immunological responses and efficacy of gamma-irradiated V3526 vaccine formulations against subcutaneous and aerosol challenge with Venezuelan equine encephalitis virus subtype IAB.

Shannon S Martin, Russell R Bakken, Cathleen M Lind, Patricia Garcia, Erin Jenkins, Pamela J Glass, Michael D Parker, Mary Kate Hart, Donald L Fine

Abstract read
In one paragraph

Article in Vaccine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. COVID-19 vaccine platforms: Delivering on a promise?Human vaccines & immunotherapeutics · 2021
    Review
  9. Article
  10. Radiation-InactivatedVaccines · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Shannon S MartinDynPort Vaccine Company LLC (DVC), A CSC Company, Frederick, MD 21702, USA. smartin40@csc.com
Russell R Bakken
Cathleen M Lind
Patricia Garcia
Erin Jenkins
Pamela J Glass
Michael D Parker
Mary Kate Hart
Donald L Fine
United States Army Medical Research Institute of Infectious Diseases · USMACOM (United States) · US

Funding

Phase 2 Trial for Venezuelan Equine Encephalitis V3526UC1AI062538 · NIAID · DYNPORT VACCINE COMPANY, LLC · PI FINE, DONALD L · 2004 to 2004
$10.0M
NIAID NIH HHS 1UC1AI062538-01NIAID NIH HHS UC1 AI062538
6 · The paper itself

Abstract

We recently developed a gamma-irradiation method to inactivate V3526, a live-attenuated Venezuelan equine encephalitis virus (VEEV) vaccine candidate. Dosage and schedule studies were conducted to evaluate the immunogenicity and efficacy of gamma-irradiated V3526 (gV3526). Subcutaneous (SC) and low dosage intramuscular (IM) administration of gV3526 were highly effective in protecting mice against a SC challenge with VEEV IA/B Trinidad Donkey strain, but not against an equivalent aerosol challenge. More robust immune responses and increased protective efficacy were noted when the IM dosage of gV3526 was increased. IM administration of gV3526 formulated with either CpG or CpG plus Alhydrogel further augmented the immune response in mice and resulted in 100% protection against aerosol challenge.

Indexed as

Adjuvants, ImmunologicAluminum HydroxideAnimalsAntibodies, NeutralizingAntibodies, ViralDose-Response Relationship, ImmunologicEncephalitis Virus, Venezuelan EquineEncephalomyelitis, Venezuelan EquineGamma RaysInjections, IntramuscularInjections, SubcutaneousMiceOligodeoxyribonucleotidesSurvival AnalysisVaccines, InactivatedViral VaccinesAdjuvants, ImmunologicAluminum HydroxideAntibodies, NeutralizingAntibodies, ViralCPG-oligonucleotideOligodeoxyribonucleotidesVaccines, InactivatedViral Vaccines

Identifiers

PMID19914193
PMCPMC2815090
OpenAlexW1970963797

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.